MPROBE, INC.

Mountain View, CA · Medtech · Private

Machine learning models integrated into a software platform that analyzes pediatric echocardiograms to generate automated RV health scores and predict right ventricle dysfunction and adverse cardiac o

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Mountain View, CA
Total capital
$347K
Federal grants
$347K
1 award · 2021
Rank in peer group#37 of 45
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
12 pending

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $347K$347K
2021FEDERAL ↑EQUITY ↓Cumulative $347K$347K

Latest events

  • Federal grantHealth and Human S · Phase I · An automated system to interpret echocardiography to predict adverse outcomes in patients with right ventricular dysfunction in daily hospital practice$347K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 45 peers

Line = median

Medtech · Software

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 12
  • PendingMethods And Compositions For A Plasma Metabolite-based Test To Detect Minimal Residual Disease In Post-surgery Colorectal Cancner PatientsUSPTOApplication PCTUS2023064962
  • PendingMethods And Compositions For Providing A Preeclampsia Assessment By ProteomicsUSPTOApplication PCTUS2018063529
  • PendingQuantitative Targeted Metabolomic Analysis Based On The Mixture Of Isotope-and Nonisotope-labeled Internal StandardsUSPTOApplication PCTUS2017023863
Show all 12 patent records
  • Methods And Compositions For A Plasma Metabolite-based Test To Detect Minimal Residual Disease In Post-surgery Colorectal Cancner PatientsApplication PCTUS2023064962Pending
  • Methods And Compositions For Providing A Preeclampsia Assessment By ProteomicsApplication PCTUS2018063529Pending
  • Quantitative Targeted Metabolomic Analysis Based On The Mixture Of Isotope-and Nonisotope-labeled Internal StandardsApplication PCTUS2017023863Pending
  • Methods And Compositions For Providing A Preeclampsia Assessment With MetabolitesApplication PCTUS2017023680Pending
  • Methods And Compositions For Detecting Early Stage Bladder Cancer With Rna-seq Expression ProfilingApplication PCTUS2017023476Pending
  • Methods And Composition For Detecting Early Stage Colon Cancer With Rna-seq Expression ProfilingApplication PCTUS2017023478Pending
  • Methods And Compositions For Detection Early Stage Lung Adenocarcinoma With Rnaseq Expression ProfilingApplication PCTUS2017023474Pending
  • Methods And Compositions For Detecting Early Stage Breast Cancer With Rna-seq Expression ProfilingApplication PCTUS2017023475Pending
  • Clinical Method For The Population Screening Of Adult Metabolic Disorder Associated With Chronic Human DiseaseApplication PCTUS2017023447Pending
  • Methods And Compositions For Detection Early Stage Lung Squamous Cell Carcinoma With Rnaseq Expression ProfilingApplication PCTUS2017023473Pending
  • Methods And Compositions For Detecting Early Stage Ovarian Cancer With Rnaseq Expression ProfilingApplication PCTUS2017015554Pending
  • Methods And Compositions For Of Providing An Early Stage Ovarian Cancer Assessment With MetabolitesApplication PCTUS2017014406Pending
  • LENIMA FIELD DIAGNOSTICS LLCSimilar federal contract value in Medtech · null in contracts
  • JT-MESH DIAGNOSTICS LLCSimilar federal contract value in Medtech · null in contracts
  • BLUMIO, INC.Similar federal contract value in Medtech · null in contracts
  • Lynthera CorporationSimilar federal contract value in Medtech · null in contracts
  • CATS TONOMETER, LLCSimilar federal contract value in Medtech · null in contracts
  • GODX INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .